![]() This alliance confirms our purpose to supply all Latin America with innovative treatments that contribute to improve the quality of life”, stated Rodríguez. “We are excited to collaborate with the target of increasing vaccination rates in Latin America, assisting patients, physicians, and governments in this effort. Moderna is a leading company in the battle against the pandemic and we are proud to be partnered in this mission”, said Patricio Rodriguez, CEO of ADIUM. “We are delighted to partner with Moderna to bring the COVID-19 vaccine to our Latin American population. The company is headquartered in Montevideo, owns four pharmaceutical manufacturing sites in the region, with presence in Argentina, Bolivia, Brazil, Central America, Chile, Colombia, Ecuador, Mexico, Paraguay, Peru, and Uruguay.Īs part of the agreement, ADIUM will collaborate with Moderna in supply contract management with governments and currently in effect, and also continuous medical education, as well as the development of new agreements in countries where SPIKEVAX is not yet available. reached an agreement for the distribution and commercialization throughout Latin America for SPIKEVAX, the vaccine developed by Moderna against SARS-CoV-2.ĪDIUM is a leading pharmaceutical company that develops, produces and commercializes innovative high-quality products, and specializes in the therapeutic areas of oncology, cardiology, central nervous system, gynecology, among others. Leading company in pharmaceutical innovation, headquartered in our country, signs an unprecedented agreement for the arrival of COVID-19 vaccinesĪDIUM Pharma and Moderna Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |